Related Experiment Videos
[Angiogenesis and its inhibitors]
Abstract:
Angiogenesis is controlled by a local balance between stimulators and inhibitors of growth of new vessels. Aberrant angiogenesis is closely involved in invasion/metastasis as well as malignant tumors. There are several strategies for inhibiting tumor angiogenesis. In this article, we investigator whether endogenous angiogenesis inhibitors, plasminogen activator and matrix metalloprotease inhibitors and Flk-1 antagonists could be anti-angiogenesis targets of intrinsic interest.
Insights
This study explores endogenous angiogenesis inhibitors, including plasminogen activator and matrix metalloprotease inhibitors, as potential anti-angiogenesis targets. These factors are crucial for controlling new blood vessel growth in malignant tumors.
Area of Science:
- Oncology
- Vascular Biology
- Biochemistry